Overview
Malin Hultcrantz is a Hematologist and an Oncologist in New York, New York. Dr. Hultcrantz is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration. Dr. Hultcrantz is currently accepting new patients.
Her clinical research consists of co-authoring 145 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 20 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
530 E 74th St, New York, NY 10021
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Memorial Sloan Kettering Bergen
Neha Korde is a Hematologist and an Oncologist in Montvale, New Jersey. Dr. Korde is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Korde is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Sham Mailankody is a Hematologist and an Oncologist in New York, New York. Dr. Mailankody is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mailankody is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Hani Hassoun is a Hematologist and an Oncologist in New York, New York. Dr. Hassoun is rated as an Elite provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Hassoun is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Hultcrantz isElite. Learn about Multiple Myeloma.
- Myeloproliferative Neoplasms (MPN)Dr. Hultcrantz isElite. Learn about Myeloproliferative Neoplasms (MPN).
- Relapsed Refractory Multiple Myeloma (RRMM)
- Smoldering Multiple MyelomaDr. Hultcrantz isElite. Learn about Smoldering Multiple Myeloma.
- Distinguished
- PlasmacytomaDr. Hultcrantz isDistinguished. Learn about Plasmacytoma.
- Schnitzler SyndromeDr. Hultcrantz isDistinguished. Learn about Schnitzler Syndrome.
- Advanced
- Mesenteric Venous ThrombosisDr. Hultcrantz isAdvanced. Learn about Mesenteric Venous Thrombosis.
- Polycythemia VeraDr. Hultcrantz isAdvanced. Learn about Polycythemia Vera.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Hultcrantz isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Hultcrantz isExperienced. Learn about Agranulocytosis.
- Blood ClotsDr. Hultcrantz isExperienced. Learn about Blood Clots.
- Bone Marrow AspirationDr. Hultcrantz isExperienced. Learn about Bone Marrow Aspiration.
- Breast CancerDr. Hultcrantz isExperienced. Learn about Breast Cancer.
- Deep Vein ThrombosisDr. Hultcrantz isExperienced. Learn about Deep Vein Thrombosis.